Yonezawa M, Takahata M, Matsubara N, Watanabe Y, Narita H
Research Laboratories, Toyama Chemical Co., Ltd, Japan.
Antimicrob Agents Chemother. 1995 Sep;39(9):1970-2. doi: 10.1128/AAC.39.9.1970.
The mutations in the quinolone resistance-determining region of the gyrA gene from clinical isolates of Pseudomonas aeruginosa were determined by DNA sequencing. The strains were isolated in 1989 and 1993. No mutations were detected in the clinical isolates in 1989, while five types of mutations were identified in the isolates in 1993. These mutations were as follows: group 1, a Thr residue to an Ile residue at position 83 (Thr-83-Ile); group 2, Asp-87-Asn; group 3, Thr-83-Ile and Asp-87-Gly; group 4, Thr-83-Ile and Asp-87-Asn; group 5, Thr-83-Ile and Asp-87-His. Three types of double mutations (groups 3, 4, and 5) have not been described previously. These mutations were homologous to the Ser-83-Leu, Asp-87-Asn, and Asp-87-Gly changes observed in Escherichia coli. Thus, DNA gyrase A subunit mutations are implicated in resistance to quinolones in P. aeruginosa as well as E. coli.
通过DNA测序确定了铜绿假单胞菌临床分离株gyrA基因喹诺酮耐药决定区的突变情况。这些菌株分别于1989年和1993年分离得到。1989年的临床分离株未检测到突变,而1993年的分离株鉴定出五种类型的突变。这些突变如下:第1组,第83位的苏氨酸残基突变为异亮氨酸残基(Thr-83-Ile);第2组,Asp-87-Asn;第3组,Thr-83-Ile和Asp-87-Gly;第4组,Thr-83-Ile和Asp-87-Asn;第5组,Thr-83-Ile和Asp-87-His。三种类型的双突变(第3、4和5组)此前未曾报道。这些突变与在大肠杆菌中观察到的Ser-83-Leu、Asp-87-Asn和Asp-87-Gly变化同源。因此,DNA促旋酶A亚基突变与铜绿假单胞菌和大肠杆菌对喹诺酮的耐药性有关。